Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial
By R. Beck, Tonya D. Riddlesworth, K. Ruedy, A. Ahmann, R. Bergenstal, S. Haller, C. Kollman, D. Kruger, J. McGill, W. Polonsky and 3 more. Journal of the American Medical Association (JAMA), 2017
1,082 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Surgery
View Paper: https://www.semanticscholar.org/paper/8564744f4efd477ed52d7532b1540bfb7ebb689c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
- Boris P. Kovatchev
- Eric Renard
- Claudio Cobelli
- J. Hans DeVries
- I. Hirsch
- D. Rodbard
- Chao Yu
- Jiming Liu
In Surgery
- Boris P. Kovatchev
- Eric Renard
- Claudio Cobelli
- J. Hans DeVries
- I. Hirsch
- Chao Yu
- Jiming Liu
- Shamim Nemati
Citations in the corpus
- Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019, background): “A1C is currently recognized as the key surrogate marker for the development of long-termdiabetes complications in people with type 1 and type 2 diabetes and has been used as the primary end point for many CGM studies (1,3,4,6,33,34).”